While it began as a revolutionary research tool a decade ago, NGS is now the method of choice for simultaneous genomic profiling of multiple cancer markers. For hospitals, the advantages of NGS over traditional methods are indisputable in terms of time savings, tissue preservation, and a precision oncology approach to patient care.
Learn how community hospitals are benefiting from in-house NGS in an article from Luca Quagliata, PhD, Thermo Fisher Global Head of Medical Affairs.
Get our educational guide and learn:
Now any hospital pathology lab can perform NGS. A highly automated workflow makes it easy for you to get started with your existing staff and infrastructure. Intuitive reporting enables you to deliver the results that capture critical information and links biomarkers to relevant evidence.
As your hospital's needs evolve, your flexible NGS platform easily adapts to meet new demands for different types of assays.
One Platform. Multiple Applications.
See how University Hospital Basel is using NGS testing to inform treatment decisions for lung cancer patients.
We've detected your location to be Japan.
Sorry, you cannot access this website. The content on www.oncomine.com is only intended for healthcare professionals. Formore information on our research solutions, please visit ThermoFisher.com
このウェブサイトは、日本国内の医療関係者の方への情報提供を目的としており、一般の方に対する情報提供を目的としたものではないことをご了承ください。研究用製品の情報はThermoFisher.comよりご覧ください。